Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis-Reference-Cited by-同舟云学术

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis

Published:2016-05-20 Issue:11 Volume:10 Page:1294-1302
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:ECCOJC

Author:

Atreya Raja,Bloom Stuart,Scaldaferri Franco,Gerardi Viviana,Admyre Charlotte,Karlsson Åsa,Knittel Thomas,Kowalski Jan,Lukas Milan,Löfberg Robert,Nancey Stephane,Petryka Robert,Rydzewska Grazyna,Schnabel Robert,Seidler Ursula,Neurath Markus F.,Hawkey Christopher

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/10/11/1294/13746375/jjw103.pdf

Reference33 articles.

1. Ulcerative Colitis

2. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

3. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

4. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

5. Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions between toll‐like receptors signaling pathway and gut microbiota in host homeostasis;Immunity, Inflammation and Disease;2024-07

2. New targeted pharmacotherapy and experimental therapies for inflammatory bowel disease;Journal of Integrative Medicine and Research;2024-07

3. Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future;Future Pharmacology;2024-03-14

4. Toll-like receptors in inflammatory bowel disease: A review of the role of phytochemicals;Phytomedicine;2024-01

5. Engaging natural antibody responses for the treatment of inflammatory bowel disease via phosphorylcholine-presenting nanofibres;Nature Biomedical Engineering;2023-11-27